Tubeimoside-1 Exerts Cytotoxicity in HeLa Cells through Mitochondrial Dysfunction and Endoplasmic Reticulum Stress Pathways-Reference-Cited by-同舟云学术

Tubeimoside-1 Exerts Cytotoxicity in HeLa Cells through Mitochondrial Dysfunction and Endoplasmic Reticulum Stress Pathways

Published:2009-02-12 Issue:3 Volume:8 Page:1585-1593
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Xu Yang¹,Chiu Jen-Fu¹,He Qing-Yu¹,Chen Feng¹

Affiliation:

1. School of Biological Sciences, and Department of Anatomy, The University of Hong Kong, Hong Kong SAR, China, and Institute of Life and Health Engineering and Guangdong Provincial Key Laboratory of Bioengineering Pharmaceutics/National Research Center of Genetic Medicine, Jinan University, Guangzhou 510632, China

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr801001j

Reference47 articles.

1. Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line

2. New Triterpenoid Saponins from Bulbs ofBolbostemma paniculatum

3. Potent Anti-Tumor Activity and Low Toxicity of Tubeimoside 1 Isolated fromBolbostemma paniculatum

4. Apoptosis in the Pathogenesis and Treatment of Disease

5. The Fas Signaling Pathway: More Than a Paradigm

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer;Journal of Ethnopharmacology;2025-01

2. Chinese endemic medicinal plant Bolbostemma paniculatum (Maxim.) Franquet: A comprehensive review;Frontiers in Pharmacology;2022-09-07

3. TUBEIMOSIDE-1, A TRITERPENOID SAPONIN: AN UPDATE ON ITS PHARMACOLOGICAL EFFECTS;Asian Journal of Pharmaceutical and Clinical Research;2022-09-07

4. Tubeimoside-1: A review of its antitumor effects, pharmacokinetics, toxicity, and targeting preparations;Frontiers in Pharmacology;2022-07-15

5. Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway;Phytomedicine;2022-05